Acquiring Company
Abeona Therapeutics
Acquired Company
Ellodi Pharmaceuticals L.P
England
WilmingtonBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
On November 6, 2026, Abeona Therapeutics Inc. entered into an Asset Purchase Agreement with Ellodi Pharmaceuticals, L.P. to acquire substantially all assets related to the clinical-stage candidate APT-1011. This transaction is intended to advance the development of APT-1011 for treating eosinophilic esophagitis. The deal includes an issuance of common stock and potential future milestone payments based on regulatory approvals and sales.
Quick answer
Abeona Therapeutics is acquiring Ellodi Pharmaceuticals L.P, announced November 9, 2026. Abeona Therapeutics is based in England, United Kingdom.
- How much did Abeona Therapeutics pay for Ellodi Pharmaceuticals L.P?
- The deal value was not disclosed.
- What does Abeona Therapeutics do?
- Abeona Therapeutics Inc. is a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids.
- Where are Abeona Therapeutics and Ellodi Pharmaceuticals L.P based?
- Abeona Therapeutics is based in England, United Kingdom. Ellodi Pharmaceuticals L.P is based in Wilmington, Delaware, United States.
- Who are the decision-makers at Abeona Therapeutics?
- Fundz holds 2 contacts at Abeona Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Pelthos to merge with Castle Creek Biosciences (October 30, 2026)
- Ambrose Healthcare acquires AM-Pharma for rare disease (October 20, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
Who to call at Abeona Therapeutics, and when
When Abeona Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Abeona Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abeona Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abeona Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abeona Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ellodi Pharmaceuticals L.P?
Ellodi Pharmaceuticals L.P was acquired by Abeona Therapeutics, based in England. The deal was reported on November 9, 2026. Abeona Therapeutics Inc. is a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids. Abeona Therapeutics is publicly traded (ABEO) and operates in Biotechnology.
When did Abeona Therapeutics acquire Ellodi Pharmaceuticals L.P?
Abeona Therapeutics's acquisition of Ellodi Pharmaceuticals L.P was reported on November 9, 2026. On November 6, 2026, Abeona Therapeutics Inc. entered into an Asset Purchase Agreement with Ellodi Pharmaceuticals, L.P. to acquire substantially all assets related to the clinical-stage candidate APT-1011. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ellodi Pharmaceuticals L.P do?
Ellodi Pharmaceuticals, L.P. is a pharmaceutical company dedicated to the development of innovative treatments for various medical conditions. It is privately held, operating in Biotechnology, and is based in Wilmington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.